Medications

Treating tuberculosis when antibiotics no longer work

Researchers have identified new antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans. In addition, some of the discovered substances may allow for a renewed treatment of tuberculosis ...

Oncology & Cancer

A potential early esophageal cancer antigen: DDX53

A new research paper has been published in Oncoscience, titled "An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen."

Psychology & Psychiatry

New postpartum depression drug comes with hefty price tag

A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients won't be able to afford the medication.

page 2 from 40